Benefits of lipid-lowering therapy in men with elevated apolipoprotein B are not confined to those with very high low density lipoprotein cholesterol
- 15 March 1994
- journal article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 23 (4) , 899-906
- https://doi.org/10.1016/0735-1097(94)90635-1
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Epidemiology of triglycerides: A view from FraminghamThe American Journal of Cardiology, 1992
- The Pathogenesis of Coronary Artery Disease and the Acute Coronary SyndromesNew England Journal of Medicine, 1992
- The Pathogenesis of Coronary Artery Disease and the Acute Coronary SyndromesNew England Journal of Medicine, 1992
- Atherosclerosis: inhibition of regression as therapeutic possibilities.Heart, 1991
- Composition of atherosclerotic plaques in coronary arteries in women <40 years of age with fatal coronary artery disease and implications for plaque reversibilityThe American Journal of Cardiology, 1991
- Ten-Year Mortality from Cardiovascular Disease in Relation to Cholesterol Level among Men with and without Preexisting Cardiovascular DiseaseNew England Journal of Medicine, 1990
- Effects of therapy with cholestyramine on progression of coronary arteriosclerosis: results of the NHLBI Type II Coronary Intervention Study.Circulation, 1984
- Plasma lipid distributions in selected North American populations: the Lipid Research Clinics Program Prevalence Study. The Lipid Research Clinics Program Epidemiology Committee.Circulation, 1979
- Natural history of myocardial infarction in the coronary drug project: Long-term prognostic importance of serum lipid levelsThe American Journal of Cardiology, 1978
- Quantitative coronary arteriography: estimation of dimensions, hemodynamic resistance, and atheroma mass of coronary artery lesions using the arteriogram and digital computation.Circulation, 1977